Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Fatigue, depression, and physical impairment in multiple sclerosis.
[Cognitive disorders in adolescents with multiple sclerosis: problem and methods].
MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.
Sex-specific environmental influences affecting MS development.
Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
Inhibition of Myeloperoxidase at the Peak of Experimental Autoimmune Encephalomyelitis Restores Blood-Brain-Barrier Integrity and Ameliorates Disease Severity.
Robust myelin quantitative imaging from multi-echo T2 MRI using edge preserving spatial priors.
An adverse lipid profile is associated with disability and progression in disability, in people with MS.
[Mitoxantrone role in treatment of primary progressive multiple sclerosis].
Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.
Antineutrophil Cytoplasmic Antibodies in Patients with Idiopathic Inflammatory-Demyelinating Diseases.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
Sunshine and multiple sclerosis.
Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.
S1P signaling: new therapies and opportunities.
Modeling the Relationship among Gray Matter Atrophy, Abnormalities in Connecting White Matter, and Cognitive Performance in Early Multiple Sclerosis.
Acute Disseminated Encephalomyelitis in a Child Following Plasmodium vivax Malaria.
Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines.
The Regulation of Reactive Changes Around Multiple Sclerosis Lesions by Phosphorylated Signal Transducer and Activator of Transcription.
Multiple sclerosis in US minority populations: Clinical practice insights.
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.
Neuroprotection and repair in multiple sclerosis.
A common anesthesiology procedure for a patient with an uncommon combination of diseases: a case report.
Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma.
Pages
« first
‹ previous
…
364
365
366
367
368
369
370
371
372
…
next ›
last »